Artemis Medicare Services Limited has informed the Exchange regarding Communication to shareholders: Intimation on TDS/ withholding tax on Dividend for FY25
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Artemis Medicare Services has informed the exchanges about tax deduction at source (TDS) provisions on its final dividend for FY25. The Board of Directors, at its meeting on May 12, 2025, had recommended a final dividend of Re. 0.45 per equity share (face value Re. 1 each). The record date for dividend entitlement is Friday, July 11, 2025, and the dividend will be paid only after approval at the company's 21st Annual General Meeting. TDS will be deducted at 10% for resident shareholders with a valid PAN linked with Aadhaar, 20% for those without a valid PAN, and nil for resident individuals submitting Form 15G/15H or whose total dividend from the company in FY26 does not exceed Rs. 10,000. Non-resident shareholders will face 20% TDS (plus applicable surcharge and cess) or the lower DTAA rate, subject to submission of documents like TRC, Form 10F, PAN, and self-declaration. Shareholders must submit relevant tax exemption documents to the Registrar (Alankit Assignments Limited) at rta@alankit.com by Wednesday, July 16, 2025.
This is a routine regulatory communication with no new business impact. Shareholders should update PAN, bank, and contact details with their depositories or the RTA, and submit exemption forms (Form 15G/15H, TRC, Form 10F, etc.) by July 16, 2025, to avoid higher TDS. The final dividend of Re. 0.45 per share is subject to shareholder approval at the upcoming AGM.